Scientists track experimental Drug's journey in healthy men
NCT ID NCT07479745
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study gives 10 healthy men a single dose of GRT6019 with a radioactive tracer to see how the drug is broken down and eliminated. Researchers will measure radioactivity in urine and stool to understand the drug's metabolism. The study does not aim to treat any condition, but to gather essential data for future development.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GRT6019 (also called Tegacorat or GRM-01) with a radioactive tracer
- What this could lead to
- If successful, this study will show how the body processes and eliminates GRT6019, which is needed before it can be tested as a potential treatment.
- What could go wrong
- This is a very early, small study in just 10 healthy men. It is not designed to test if the drug works or is safe for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MALE VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Quotient Sciences
RECRUITINGNottingham, NG11 6JS, United Kingdom
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.